{
    "Trade/Device Name(s)": [
        "MyGlucoHealth Wireless System"
    ],
    "Submitter Information": "Entra Health Systems",
    "510(k) Number": "K143169",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081703"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "December 3, 2015",
    "Summary Letter Received Date": "December 11, 2015",
    "Submission Date": "September 1, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Glucose Oxidase, Glucose"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MyGlucoHealth Wireless Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase enzymatic method"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for MyGlucoHealth Wireless System for quantitative measurement of blood glucose in diabetic self-testing via wireless-enabled meter.",
    "Indications for Use Summary": "Intended for self-testing by people with diabetes at home to monitor effectiveness of glucose control using whole blood from various sites; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}